Status:
COMPLETED
Perioperative Troponin I and NT Pro-BNP in Lung Resection
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Conditions:
Cardiac Ischemia
Thoracic Cancer
Eligibility:
All Genders
45+ years
Brief Summary
After lung resection, troponin elevation may be regulated by mechanisms other than myocardial ischemia. Perioperative natriuretic peptides measurement may help identify changes in ventricular function...
Detailed Description
Objectives: To evaluate the incidence and magnitude of perioperative N-terminal pro brain natriuretic peptide (NT-proBNP) and high-sensitivity troponin I (Tn I) elevation in patients undergoing pulmon...
Eligibility Criteria
Inclusion
- Age ≥45 years old
- Patients undergoing elective surgery for lung resection
Exclusion
- Patients undergoing urgent, emergent, or nonthoracic surgery
- Patients or family did not consent to participate
- Presence of symptoms related with infection or sepsis
- Patients with a documented history of severe heart failure and/or ejection fraction lower than 30%
Key Trial Info
Start Date :
May 19 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
475 Patients enrolled
Trial Details
Trial ID
NCT04749212
Start Date
May 19 2021
End Date
January 31 2025
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari Vall d'Hebron
Barcelona, Spain